Atlas Trials

The Role of FGF23 and Asymmetric Dimethylarginine (ADMA) in Chronic Kidney Disease

Clinical trial NCT01317186 · UNKNOWN

Trial details

NCT number
NCT01317186
Sponsor
Ankara Education and Research Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Metabolic DiseasesChronic Kidney Disease
Start date
2011-03-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.